ホーム › 食道腺癌 › ニューヨーク

ニューヨークにおける食道腺癌の臨床試験

ニューヨーク内の拠点で、食道腺癌に関する20件の研究が参加者を募集しています。

ニューヨーク内の都市

公式研究テキスト（英語）

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Northwell Health Imbert Cancer Center, Bay Shore
Roswell Park Cancer Institute, Buffalo
Northwell Health Cancer Institute at Huntington, Greenlawn
他7件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/10/05更新 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
The New York Hospital Medical Center of Queens, Flushing
Glens Falls Hospital, Glens Falls
他13件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05677490

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
Memorial Sloan Kettering Cancer Center, New York
Local Institution - 0274, Rochester

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Memorial Sloan-Kettering Cancer Center, New York
New York Cancer & Blood Specialists, Shirley

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Memorial Sloan Kettering Cancer Center Pharmacy (IMP ship to address), Long Island City
Memorial Sloan Kettering Cancer Center Pharmacy (IMP storage location), Long Island City
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
他2件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07392892

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Columbia University Irving Medical Center, New York

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

New York Oncology Hematology, Albany
Weill Cornell Medicine - New York Presbyterian Hospital, New York

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/21更新 · NCT07546812

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
他1件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/14更新 · NCT07818018

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Long Island Jewish Medical Center, Manhasset
Columbia Universtiy, New York
University of Rochester Medical Center, Rochester

被験者募集中

18歳〜89歳 · 全性別 · 2026/09/11更新 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, New York
Research Site, New York
Research Site, New York
他2件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NYU Langone Health, New York
Icahn School of Medicine At Mount Sinai Prime, New York
Clinical Research Alliance, Inc, Westbury
他1件

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

START New York, Lake Success
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
他7件

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Long Island Jewish Medical Center, New Hyde Park
Weill Cornell Medicine, New York
University of Rochester, Rochester

被験者募集中

18歳〜89歳 · 全性別 · 2026/07/01更新 · NCT05530343

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Research Site, New York

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/12更新 · NCT07284186

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York

被験者募集中第2相

18歳以上 · 全性別 · 2026/04/23更新 · NCT06340711

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

NYU Langone, New York
Memorial Sloan Kettering Cancer Center, New York

被験者募集中第1相

18歳以上 · 全性別 · 2026/03/05更新 · NCT04900818

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/02/11更新 · NCT06623396

Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

Roswell Park Cancer Institute, Buffalo

被験者募集中第2相

18歳以上 · 全性別 · 2026/01/02更新 · NCT04682158

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Roswell Park Cancer Institute, Buffalo

被験者募集中第2相

18歳以上 · 全性別 · 2025/12/16更新 · NCT05651594

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。